Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-21

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for insulin lispro (and its diluent) from Eli Lilly, signaling an update to the product's regulatory status, typically i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DILUENT (diluents)
  • insulin lispro (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)